Stay updated on Imatinib in Recurrent Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imatinib in Recurrent Psoriasis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the page otherwise remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-11-03T23:18:35.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A sitewide NIH notice was added about transition updates and the terminology change described under Executive Order 14434. The site revision advanced from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-20T22:48:19.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T23:06:35.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The 403 page content and related HTML were removed, suggesting the study details page now renders normally and presents the trial information and related navigation.
    Difference
    0.5%
    Check dated 2026-09-29T23:00:44.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content (including documents and details), replacing the previously accessible trial information with an access-restricted view.
    Difference
    17%
    Check dated 2026-09-22T23:17:00.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.7.0, replacing Revision: v3.6.6. This indicates an update to the page's version metadata rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-09-15T21:40:32.000Z thumbnail image

Stay in the know with updates to Imatinib in Recurrent Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.